INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

Clinical trial NCT03547297 · TERMINATED

Trial details

NCT number: NCT03547297
Sponsor: Alnylam Pharmaceuticals
Status: TERMINATED
Study type: OBSERVATIONAL

Acute Hepatic Porphyria Hepatic Porphyrias Acute Intermittent Porphyria (AIP)Hereditary Coproporphyria (HCP)Variegate Porphyria (VP)ALA Dehydratase Deficient Porphyria (ADP)Porphyria Acute

Start date: 2018-05-29
Primary completion: 2019-01-15
Enrollment: 212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.